{"DataElement":{"publicId":"6596703","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage Initial Therapy Type","preferredDefinition":"Text term that represents the initial therapy as related to acute leukemia treatment regimens.","longName":"6591121v1.0:6594392v1.0","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6591121","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage First Therapeutic Procedure","preferredDefinition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001)_Preceding all others in time or space or degree._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"2674132v1.0:6591119v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"2674132","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage","preferredDefinition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells.  The prognosis is usually unfavorable.  (WHO, 2001) -- 2003","longName":"C7464","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Leukemia of Ambiguous Lineage","conceptCode":"C7464","definition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"383619F5-D1D1-275D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-21","modifiedBy":"ONEDATA","dateModified":"2007-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6591119","version":"1","preferredName":"First Therapeutic Procedure","preferredDefinition":"Preceding all others in time or space or degree.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"C25509:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D019C93-7413-579A-E053-F662850A3C44","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D019C93-7424-579A-E053-F662850A3C44","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeDescription":"Created for CDE Request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6594392","version":"1","preferredName":"ALAL Therapy Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6594392v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Interfant06","valueDescription":"Interfant 06","ValueMeaning":{"publicId":"6334920","version":"1","preferredName":"Interfant 06","longName":"6334920","preferredDefinition":"A clinical study protocol initiated in 2006 designed to improve the treatment for infant acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interfant-06 Protocol","conceptCode":"C156939","definition":"A clinical study protocol initiated in 2006 designed to improve the treatment for infant acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E7B1B6E-7E26-5D95-E053-F662850AC639","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-12","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7D4119C1-F7D2-542D-E053-F662850A6E86","beginDate":"2018-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-17","modifiedBy":"ONEDATA","dateModified":"2018-12-17","deletedIndicator":"No"},{"value":"N/A","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7D4119C1-F7DC-542D-E053-F662850A6E86","beginDate":"2018-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-17","modifiedBy":"ONEDATA","dateModified":"2018-12-17","deletedIndicator":"No"},{"value":"Hybrid","valueDescription":"Hybrid","ValueMeaning":{"publicId":"2575108","version":"1","preferredName":"Hybrid","longName":"2575108","preferredDefinition":"Being comprised of mixed attributes or parts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hybrid","conceptCode":"C128790","definition":"Being comprised of mixed attributes or parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F271-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-24","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7D4119C1-F7E6-542D-E053-F662850A6E86","beginDate":"2018-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-17","modifiedBy":"ONEDATA","dateModified":"2018-12-17","deletedIndicator":"No"},{"value":"ALL","valueDescription":"Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"3322383","version":"1","preferredName":"Acute Lymphoblastic Leukemia","longName":"3322383","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BB5D-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"ONEDATA","dateModified":"2011-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7D4119C1-F7FB-542D-E053-F662850A6E86","beginDate":"2018-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-17","modifiedBy":"ONEDATA","dateModified":"2018-12-17","deletedIndicator":"No"},{"value":"AML","valueDescription":"Acute Myeloid Leukemia","ValueMeaning":{"publicId":"4263972","version":"1","preferredName":"Acute Myeloid Leukemia","longName":"4263972","preferredDefinition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise categorized. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Myeloid Leukemia","conceptCode":"C3171","definition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-1110-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"KUMMEROA","dateModified":"2022-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7D4119C1-F810-542D-E053-F662850A6E86","beginDate":"2018-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-17","modifiedBy":"ONEDATA","dateModified":"2018-12-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D4119C1-F7B0-542D-E053-F662850A6E86","latestVersionIndicator":"Yes","beginDate":"2018-12-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-17","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeDescription":"Created for ALAL CDE request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650571","version":"1","longName":"ALL","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Initial Therapy","type":"Preferred Question Text","description":"Initial Therapy","url":null,"context":"NCIP"}],"origin":"TARGET:Therapeutically Applicable Research to Generate Effective Treatments","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D65F3F2-B9C6-5AB3-E053-F662850AE88E","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-19","modifiedBy":"COOPERM","dateModified":"2019-01-16","changeDescription":"Created for ALAL request 12.13.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}